MyFinsight
Home
Blog
About
Marketable securities,
current
$66,962K
(-31.77%↓ Y/Y)
Cash and cash
equivalents
$12,469K
(-71.74%↓ Y/Y)
Prepaid expenses and
other current assets
$1,978K
(-34.87%↓ Y/Y)
Total current assets
$81,409K
(-43.98%↓ Y/Y)
Other assets
$296K
(19.35%↑ Y/Y)
Right-of-use assets
$209K
(-78.61%↓ Y/Y)
Property and equipment,
net
$154K
(-46.34%↓ Y/Y)
Total assets
$82,068K
(-46.31%↓ Y/Y)
Total liabilities and
stockholders equity
$82,068K
(-46.31%↓ Y/Y)
Total stockholders
equity
$71,500K
(-49.15%↓ Y/Y)
Total liabilities
$10,568K
(-13.73%↓ Y/Y)
Accumulated deficit
-$482,578K
(-18.47%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$82K
(-490.48%↓ Y/Y)
Additional paid-in capital
$554,160K
(1.13%↑ Y/Y)
Total current
liabilities
$10,568K
(-8.95%↓ Y/Y)
Accrued expenses
$8,331K
(-3.49%↓ Y/Y)
Accounts payable
$2,020K
(-22.25%↓ Y/Y)
Operating lease
liabilities, current
$217K
(-42.44%↓ Y/Y)
Back
Back
Balance Sheet
PMV Pharmaceuticals, Inc. (PMVP)
PMV Pharmaceuticals, Inc. (PMVP)
source: myfinsight.com